Cf-PWV but not cr-PWV or cd-PWV is associated with cardiovascular mortality in patients with chronic kidney disease

Yan Wang1, Hui-Xin Liu2, Jie-Ran Xiong1

  • 1Department of Nephrology, Peking University People's Hospital, No. 11, Xizhimen South Street, Beijing, 100044, China.

BMC Nephrology
|November 3, 2025
PubMed

Insights

Carotid-femoral pulse wave velocity (cf-PWV) predicts cardiovascular death in chronic kidney disease (CKD) patients over 10 years. Other pulse wave velocity measures, cr-PWV and cd-PWV, did not show significant associations with mortality.

Area of Science:

  • Cardiovascular research
  • Nephrology
  • Biomedical engineering

Background:

  • Chronic kidney disease (CKD) is linked to increased cardiovascular (CV) mortality.
  • Carotid-femoral pulse wave velocity (cf-PWV) is a known predictor of CV mortality in CKD.
  • Limited data exists on the predictive value of carotid-radial (cr-PWV) and carotid-dorsalis pedis (cd-PWV) in CKD patients.

Purpose of the Study:

  • To investigate the association between cf-PWV, cr-PWV, and cd-PWV with CV mortality in non-dialysis CKD patients.
  • To evaluate the long-term predictive performance of cf-PWV for CV mortality.

Main Methods:

  • Enrolled 233 non-dialysis CKD patients (eGFR < 60 mL/min/1.73 m²).
  • Measured baseline arterial stiffness using cf-PWV, cr-PWV, and cd-PWV.
  • Prospectively followed patients for all-cause and CV mortality, using Cox and competing risk models.

Main Results:

  • During a median follow-up of 9.0 years, 144 patients died, including 76 CV deaths.
  • Adjusted analysis revealed cf-PWV as an independent predictor of CV mortality (HR 1.198).
  • cf-PWV demonstrated significant predictive value for CV death at 1, 3, 5, and 10 years.

Conclusions:

  • cf-PWV is a significant independent predictor of long-term CV mortality in CKD patients.
  • cr-PWV and cd-PWV were not associated with all-cause or CV mortality in this cohort.
  • cf-PWV offers valuable prognostic information for cardiovascular risk stratification in CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
540
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
309
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
553
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
208
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
412
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K